DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference:

  • Kevin Sayer, President and Chief Executive Officer, will present an update on the company at the J.P. Morgan 36th Annual Healthcare Conference in San Francisco, California, on Tuesday, January 9, 2018, at 11:00 a.m. (PST). The presentation, which will occur live at the Westin St. Francis Hotel, will be concurrently webcast.

The link to the webcast will be available on the DexCom website at www.dexcom.com by navigating to “Our Company,” then “Investor Relations,” and finally “Events and Webcasts” and will be archived there for future reference.

About DexCom, Inc.

DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital.

DexCom, Inc.Steven R. PacelliExecutive Vice President, Strategy and Corporate Development(858) 200-0200

DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more DexCom Charts.
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more DexCom Charts.